SEC Form 4 · accession 0000899243-18-015817
AMEDISYS INC · AMED
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey A Rideout
Director
Period of report
Jun 6, 2018
Accepted (ET)
Jun 8, 2018 · 8:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000896262
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 6, 2018 | A | 1,863 | $0.00 | A | 7,196 | D | |
| Common StockF3 | Jun 8, 2018 | S | 1,528 | $78.66 | D | 5,668 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares reported are subject to time-based vesting conditions and will vest 100% on June 6, 2019, predicated upon the Reporting Person's continued service as a non-employee member of the Issuer's Board of Directors through the vesting date.
- F2The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2018.
- F3The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.40 to $78.855, inclusive. The Reporting Person undertakes to provide to Amedisys, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.